US Deflazacort Market Trends in Corticosteroid Treatment

ha aggiunto una foto Altre informazioni

2026-08-20 10:14:07 -

The US deflazacort market is supported by increasing demand for corticosteroid therapy, particularly for the management of Duchenne muscular dystrophy (DMD) and other inflammatory or immune-related conditions. Growing awareness of DMD, improved diagnosis, and greater access to specialized treatment are contributing to market demand. Continued advances in rare disease care and the availability...

0 Commenti 0 condivisioni 98 Views 0 Anteprima